Skip to main content

6-Mercaptopurine: Efficacy and Bone Marrow Toxicity in Childhood Acute Lymphoblastic Leukemia

Association with Low (Thio)purine enzyme activity

  • Chapter
Purine and Pyrimidine Metabolism in Man X

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Maybaum, J., and Mandel H.G., 1983, Unilateral chromatid damage: a new basis for 6-thioguanine toxicity. Cancer Res, 43:3852–3856.

    CAS  PubMed  Google Scholar 

  2. Bodell W.J., 1981, Molecular densimetry of sister chromatid exchange induction in 9L cells trated with 6-thioguanine. Mutagen, 6:175–177.

    Google Scholar 

  3. Covey J.M., Dincalci M., and Kohn, K.W., 1986, Production of DNA-protein crosslinks (DPC) by 6-thioguanine (TG) and 2′-deoxy-6-thioguanosine (TGdR) in L1210 cells in vitro. Proc. Am. Assoc. Cancer Res., 27:17.

    Google Scholar 

  4. Bokkerink J.P.M., Stet E.H., De Abreu R.A., Damen F.J.M., Hulscher T.W., Bakker M.A.H., and van Baal J.M., 1993, 6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts. Biochem, Pharmacol., 45:1455–1463.

    Article  CAS  Google Scholar 

  5. Bokkerink J.P.M., Bakker M.A.H., Hulscher T. W., De Abreu R.A., and Schretlen E.D.A.M., 1988, Purine de novo synthesis as the basis of synergism of methotrexate and 6-mercaptopurine in human malignant lymphoblasts of different cell lineages. Biochem. Pharmacol., 37:2321–2327.

    CAS  PubMed  Google Scholar 

  6. Vogt M.H.J., Stet E.H. De Abreu R.A., Bokkerink J.P.M., Lambooy L.H.J. and Trijbels J. M. F., 1993, The importance of methylthio-IMP for methylmercaptopurine ribonucleoside (Me-MPR) cytotoxicity in Molt F4 human malignant T-lymphoblasts. Biochim. Biophys. Acta, 1181:189–194.

    CAS  PubMed  Google Scholar 

  7. Stet E.H., De Abreu R.A., Bokkerink J.P.M., Blom H.J., Lambooy L.H.J., Vogels-Mentink T.M., de Graaf-Hess A.C., van Raay-Selten B, and Trijbels J.M.F., 1994 Biochem. J., 304:163–168.

    CAS  PubMed  Google Scholar 

  8. Lambooy L.H., Leegwater P.A., van den Heuvel L.P., Bokkerink J.P., and De Abreu R.A., 1998, Inhibition of DNA methylation in malignant MOLT F4 lymphoblasts by 6-mercaptopurine. Clin. Chem., 44:556–559.

    CAS  PubMed  Google Scholar 

  9. Lennard L., Lilleyman J.S., van Loon J., Weinshilboum R.M., 1990, Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet, 336:225–229.

    Article  CAS  PubMed  Google Scholar 

  10. Janka-Schaub G.E., Erb N., and Harms D., 1994, Randomized comparison of 6-mercaptopurine (6MP) vs 6-thioguanine (6TG) in maintenance treatment of childhood acute lymphoblastic leukemia (ALL); differing metabolism and hematologic toxicity. Med.Ped. Oncol., 23:197.

    Google Scholar 

  11. Kerstens P.J.S.M., Stolk J.N., Hilbrands L.B., van de Putte L.B.A., De Abreu R.A., and Boerbooms, A.M.Th., 1993, 5′-nucleotidase and azatioprine-related bone marrow toxicity. Lancet, 342:1245–1246.

    Article  CAS  PubMed  Google Scholar 

  12. Kerstens P.J.S.M., Stolk J.N., De Abreu R.A., Lambooy L.H.J., van de Putte L.B.A., and Boerbooms, A.M.Th., 1995, Azatioprine-related bone marrow toxicity and low activities of purine enzymes in patients with rheumatoid arthritis. Arthritis & Rheumatism, 38:142–145.

    CAS  Google Scholar 

  13. McLeod H.L., Lin J.S., Scott E P., Pui C.H., and Evans W.E., 1994, Thiopurine methyltransferase activity in American white subjects and black subjects. Clin. Pharmacol. Ther., 55:15–20.

    CAS  PubMed  Google Scholar 

  14. Otterness D., Szumlanski C., Lennard L., Klementsdal B., Aarbakke J., ParkHah J.O., Iven H., Schmiegelow K., Branum E, O′Brien J., and Weinschilboum R, 1997, Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin. Pharmacol. Ther., 62:60–73.

    Article  CAS  PubMed  Google Scholar 

  15. McLeod J.S., Coulthard S., Thomas A.E., Pritchard S.C., King D. J., Richards S.M., Eden O.B., Hall A.G., and Gibson B.E., 1999, Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukemia. Br. J. Haematol., 105:696–700.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

De Abreu, R.A. et al. (2002). 6-Mercaptopurine: Efficacy and Bone Marrow Toxicity in Childhood Acute Lymphoblastic Leukemia. In: Zoref-Shani, E., Sperling, O. (eds) Purine and Pyrimidine Metabolism in Man X. Advances in Experimental Medicine and Biology, vol 486. Springer, Boston, MA. https://doi.org/10.1007/0-306-46843-3_53

Download citation

  • DOI: https://doi.org/10.1007/0-306-46843-3_53

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46515-4

  • Online ISBN: 978-0-306-46843-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics